Dutta S, Ebling W F
Department of Pharmaceutics, State University of New York at Buffalo, Amherst, USA.
Anesthesiology. 1998 Sep;89(3):678-85. doi: 10.1097/00000542-199809000-00018.
Propofol when administered by brief infusion in a lipid-free formulation has a slower onset, prolonged offset and greater potency compared with an emulsion formulation. To understand these findings the authors examined propofol brain and lung distribution kinetics in rats.
Rats were infused with equieffective doses of propofol in emulsion (n = 21) or lipid-free formulation (n = 21). Animals were sacrificed at various times to harvest brain and lung. Arterial blood was sampled repeatedly from each animal until sacrifice. Deconvolution and moment analysis were used to calculate the half-life for propofol brain turnover (BT) and brain:plasma partition coefficient (Kp). Lung concentration-time profiles were compared for the two formulations.
Peak propofol plasma concentrations for the lipid-free formulation were 50% of that observed for emulsion formulation, whereas peak lung concentrations for lipid-free formulation were 300-fold higher than emulsion formulation. Brain Kp calculated from tissue disposition curve and ratio of brain:plasma area under the curves were 8.8 and 13, and 7.2 and 9.1 for emulsion and lipid-free formulations, respectively. BT were 2.4 and 2.5 min for emulsion and lipid-free formulations, respectively.
Significant pulmonary sequestration and slow release of propofol into arterial circulation when administered in lipid-free vehicle accounts for the lower peak arterial concentration and sluggish arterial kinetics relative to that observed with the emulsion formulation. Higher Kp for the lipid-free formulation could explain the higher potency associated with this formulation. BT were independent of formulation and correlated with values reported for effect-site equilibration half-time consistent with a distribution mechanism for pharmacologic hysteresis.
与乳剂配方相比,以无脂质配方短暂输注丙泊酚时,起效较慢、作用消退时间延长且效能更高。为了解这些发现,作者研究了大鼠体内丙泊酚在脑和肺中的分布动力学。
给大鼠输注等效剂量的乳剂(n = 21)或无脂质配方(n = 21)的丙泊酚。在不同时间处死动物以获取脑和肺组织。在处死前从每只动物反复采集动脉血。采用反卷积和矩量分析计算丙泊酚脑周转率(BT)的半衰期以及脑与血浆的分配系数(Kp)。比较两种配方的肺浓度 - 时间曲线。
无脂质配方的丙泊酚血浆峰值浓度为乳剂配方的50%,而无脂质配方的肺峰值浓度比乳剂配方高300倍。根据组织处置曲线计算的脑Kp以及脑与血浆曲线下面积之比,乳剂配方分别为8.8和13,无脂质配方分别为7.2和9.1。乳剂配方和无脂质配方的BT分别为2.4分钟和2.5分钟。
以无脂质载体给药时,丙泊酚在肺中显著潴留并缓慢释放至动脉循环,这导致相对于乳剂配方而言动脉峰值浓度较低且动脉动力学迟缓。无脂质配方的较高Kp可以解释该配方具有更高的效能。BT与配方无关,且与报道的效应部位平衡半衰期值相关,这与药理滞后的分布机制一致。